RenovoRx Announces ROTH Capital Key Opinion Leader (KOL) Webcast on June 15 Jun 12, 2023 08:30AM
RenovoRx Initiates Patient Enrollment at University of Texas Southwestern Medical Center for Pivotal Phase III TIGeR-PaC Clinical Trial Jun 1, 2023 08:30AM
RenovoRx (RNXT) Phase III Open Label TIGeR-PaC Interim Analysis Shows Promising Data That Support Continued Clinical Investigation of RenovoGemTM as a Treatment Option for Locally Advanced Pancreatic Mar 8, 2023 08:32AM
RenovoRx Phase III Open Label TIGeR-PaC Interim Analysis Shows Promising Data That Support Continued Clinical Investigation of RenovoGemTM as a Treatment Option for Locally Advanced Pancreatic Cancer Mar 8, 2023 08:30AM
RenovoRx Reports Full Year 2022 Financial Results and Achievement of Important Phase III Clinical Study Milestone Mar 2, 2023 08:30AM